Objective: Aim of this study is to analyze the change of the area under the adjusted ROC (AdjROC) curve in certain conditions via binormal distribution model using simulation studies and application of this algorithm to real data. Materials and Methods: Data sets simulated according to various conditions. PSA and age values of 125 patients who were examined prostate biopsy with pre-diagnosis of prostate cancer in Gaziosmanpasa University Faculty of Medicine Department of Urology at the years of 2005 to 2007. An algorithm and code program was written that make simulation according to various condition using PROC IML procedure in SAS statistical software.Results: According to the simulation study, if biomarker indicators in healthy group are constant and are lower or equal in healthy group than/to disease group, both adjusted AUC (AdjAUC) and AUC have small values and, no significant difference was found between them. The AUC was significantly larger when the biomarker indicators in disease group were higher. In addition, if the correlation between the covariate and biomarker is high in disease group and if AUC is approximately 0.75, then there is significant difference between adjusted AUC and AUC. PSA (Prostate Specific Antigen), a biomarker used for prostate cancer diagnosis, was analyzed based on the adjustments by age. It was found that adjusted AUC value was higher than unadjusted AUC value. Conclusions: For the adjusted ROC model being applicable, covariate and biomarker distributions must show double binormal distribution. If the biomarker can distinguish disease and healthy individuals correctly, then covariate is not needed. If correlation of healthy is approaching to 0 and correlation of disease is 0.50, and if AUC is less than 0.75, then covariate must be included in the model. Model does not work well when sample size of disease and healthy are less than 50. 
Introduction
In medicine, laboratory tests are substantially utilized when diagnosing diseases. Today, there are numerous tests that determine hematological, biochemical, and histopathological properties of individuals. When diagnosing diseases, the values obtained from these tests are the most important source of reference of the doctor in addition to the radiological imaging, physical and interventional examination findings. The results of the laboratory tests (Y, biomarker) that reveal the biological properties of individuals cannot be directly interpreted as the evidence of disease. It must be exactly clarified that in larger or smaller than which values, biomarkers point the disease. For biomarkers to be used in healthy-disease discrimination, appropriate cutting points must be determined in a valid and reliable way. [1] [2] [3] [4] ROC (Receiver Operating Characteristics Curve) analysis is a very commonly used method in determining which values of the numerical results (Y≥k, Y<k) that are obtained from laboratory tests that helps diagnosing a disease, interventional results or physical examination, points the existence of a disease or a phenomenon in a valid and a reliable way. 4 In the case where Y is a measurable variable for all the healthy and disease individuals in the society, the threshold value that will be used for distinguishing disease from healthy individuals must be a value that will minimize false positive and false negative results in diagnosis of X disease that is examined. For Y to have a distribution with similar parameters in healthy and disease group, makes it harder to use Y values in diagnosis. Furthermore, the existence of covariates (Z 1 , Z 2 ,…, Z p ) that has a change together with Y significantly affects the validity and consistency of the decisions.
Risk factors of most of the diseases include factors such as age, sex, occupation, race, BMI, total cholesterol, LDL, HDL, WBC, residence, time of affection, dose, daily activities and covariates (Z i ). These factors and the values of covariates have effect on the biomarkers that are obtained from laboratory tests. 3 When effects of covariates on the biomarker increases, wrong evaluation of disease as being healthy or wrong evaluation of healthy individuals as being disease is of concern. The use of covariates according to the corrected value instead of using laboratory results directly is of great importance in recent years. The ROC analysis that is known since 1950s, initiated the studies about adding covariate values into analysis in using biomarkers in diagnosis and treatment. In most of these researches, it is concluded that the corrections in minimizing the false positive and false negative results in accordance with the covariates, will be active in determining the threshold values and will improve the performance of diagnosis test results. The Adjusted ROC (AdjROC) model that is the adjusted measure of the classification accuracy of the diagnosis tests according to the covariates is proposed by Janes et al.
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. AdjROC is the ROC curve that uses thresholds specific to the covariate to define "test positive". In the studies of Janes et al. Adj-ROC is compared with traditional ROC curves, non-parametric or semi-parametric estimators are proposed for AdjROC and asymptotic distribution theory is developed for these estimators. 2 In this study, simulation approaches show that AdjROC estimators perform quite well for small examples.
Between the factors that affect threshold values in ROC analysis; number of units (nD, nC) of group of disease and healthy individuals that are analyzed, the distribution of Y in the group of disease and healthy individuals and its parametric values, the position of these distributions, for the scale parameters of the distribution functions to be close to each other and their intricate are the important factors. The studies that take all these factors into consideration are not seen often in resources. In trial simulation studies it is observed that positive or negative correlation of Z's with the Y's that are in the disease and healthy group and the size of these correlations cause significant change on the AUC. It is observed that the number of units in the group of disease and healthy individuals that will be analyzed, the distribution of measured YS, the difference of parametric values in the groups, and the correlation values of Z and Y within each group affects AUC significantly. As it is known, the most important factor that affects AUC is the threshold value. Combined distribution of Y according to the groups and the difference of the groups within Y distributions affect threshold value and therefore the size of AUC. 4, 23 Therefore, the activity of the method must be investigated 
Materİals and Methods
In this study, two types of data structure are used: 
Simulation Study
An algorithm and code program was written that make simulation according to various condition using PROC IML procedure in SAS statistical software.
In this program, data were simulated according to all combinations of nD and nC in the case where different disease sample size changes within the range (nD=1000, 500, 250, 100, 50, 25 and 10) and healthy sample size changes within the range (nC =2000, 1000, 500, 250, 100, 50, 25 and 10) in each trial with k=1000 repeated trials.
In the simulation, firstly diagnostic test and covariate data were simulated being separate for disease and healthy individuals. In the simulation, two types of sample unit numbers were chosen being balanced and unbalanced. In the balanced simulation, sample sizes were chosen as 1000, 500, 250, 100, 50, 25 and 10 ensuring nD=nC. [10, 20] ensuring that the ratio of (nD:nC) is 1:2. Double binormal distribution assumptions were used for conversions in the disease and healthy groups being suitable for analysis model that is used for data analysis. .
The following equations were used for conversion operations and AUC and AdjAUC calculations:
Unadjusted AUC is, (2) in this format, and, Adjusted AUC (AdjAUC) is, (3) calculated in this format. [1] [2] [3] General parameter assumptions are done from k-times repeated values by including above simulations and conversions, and the codes covering AUC and AdjAUC calculations into a loop for each SAS codes being k=1000. The differences between AUC and AdjAUC values are tested with normal distribution approach by the help of obtained asymptotic parame-Adjusted ROC Application with PCA Data Set Because of the binormal distribution assumption in adjusted ROC analysis, it is found that PSA values don't have normal distribution in normal distribution applicability test. So, it is normalized by making logarithmic conversion of PSA values and ROC analysis was applied with data that has been converted. AUC values cannot make a good distinction for disease-healthy events. When μYD=1.00, it observed that it has a distinction greater than of μYD=0.50, but still has not effective distinction. When μYD has a value greater than or equal to 1.50, the area under the curve gets larger and for μYD=2.00, it reaches the highest level. If covariate parameters increase as biomarker parameters, the distinction of disease and healthy individuals increases significantly. It is observed that, in general, the value of μYD has an effect on AUC. When μYD=0.50, it is observed that both AdjAUC and AUC have low values. When μYD=1.00, it observed that it has a distinction greater than of μYD=0.50 value, but still has not effective distinction. When μYD has a value greater than or equal to 1.50, the area under the curve gets larger and for μYD=2.00, it reaches the highest level. If covariate parameters increase as biomarker parameters, the distinction of disease and healthy individuals increases significantly. It is observed that the n=25 value is insufficient AdjAUC calculations except A weak correlation (r=0.288, p=0.163 and r=-0.072, p=0.476 respectively) was found between PCA values that has applied logarithmic conversion with age in group with prostate cancer and group without prostate cancer.
Results

Results of Simulation Study
After adopting program that has been prepared for simulation for a single data set and applying it in prostate cancer data set that has been given descriptive statistics above; AUC was found as 0.7796 in ROC analysis that is not adjusted by age. In ROC analysis adjusted by age, AdjAUC was found as 0.9995. When age variable which has shown to have a relation with PSA about prostate cancer diagnosis in literature was included into the model as a covariate, it is found that adjusted AUC is bigger than the unadjusted AUC.
Dıscussıon
ROC analysis has been commonly used to distinguish rationally between healthy and disease people using biomarkers since 1990s.
Since almost all of the biological characteristics of the individuals are interrelated, it is necessary to know how to deal with biomarker data alone from laboratory tests or in combination with covariates and how to best put laboratory test to use for diagnostic purposes. For this purpose, adjusted ROC analysis approaches based on the covariate which also take into account the covariates according to proper theoretical constructions were developed.
As seen in simulation studies, both AdjAUC and AUC had low values, and there was not significant difference between the two AUC values when sample sizes of disease and healthy group is 10≤nD=nC≤1000, healthy group parameters for the covariate and biomarker are μYC=1.00, µ σ Janes et al. conducted simulation studies in which they conducted mean increases based on data constructs with standard normal distribution, and reported that mean increases significantly increased AUC value provided that standard deviation values remain constant. 3 It seemed that when it joined to this combination of variables, covariate made significant contributions to AUC value. The results of Janes et al. are parallel to ours. 3 However, it can be seen that they did not change the values of control, covariate and biomarker. In our study, on the other hand, we studied the effects of sample size, mean and correlation coefficient on adjusted ROC analyses, also studying permutational combinations. When the sample size was over 50 (n>50), mean increased and correlation coefficient got larger in these mixed models, AdjAUC values had a tendency toward significantly increased distinguishing among values.
Although the simulation efforts in our study are very rare in literature, the results obtained are similar to those of Janes et al. When 1000≥nD=nC≥50, expected differences between AUC and AdjAUC values becomes clear. It seems that algorithm prepared works well when nD=nC≥50. When the sample size is insufficient (nD=nC<50), no significant difference is found between AUC and AdjAUC. When nD=nC<50, it seems that AdjROC method is not preferable. This result is contradictory to that of study by Janes et al. , who showed that performance of small sample sizes were satisfactory. 2 Based on the simulation study in which the sample sizes were different (nD≠nC) and ratio of healthy group to disease group (nD:nC) was 1:2, it was seen that results which were not different from the situation in which sample size were equal (nD=nC) were not different. Thus, sample size did not have any further contribution to AUC.
In the treatment in which age variable, demonstrated to have a relationship with PSA in prostate cancer diagnosis, was included in the model as covariate, there was significant difference between AdjAUC and AUC, and age variable appeared to increase the area under ROC curve (AdjAUC=0.9995, AUC=0.7796). This finding is in accordance with the ones from the simulation study. PSA has a moderate level distinguishing power and has a small correlation with age. This is parallel to the results of the simulation studies, and resulted in a 22% difference between AdjAUC and AUC. In most of the age-adjusted PSA studies, young males are also included. This higher age average in the present study did not prevent revealing of the distinguishing characteristic of age. Our results are parallel to the ones from the studies in literature. 2, 8, 20
Conclusion
In order for AdjROC model to be practical, the distributions of covariate and biomarker need to be binormal distributions. If a biomarker can distinguish well between healthy and disease individuals (AUC≥0.85), there are no need for an additional variable. However, if a biomarker cannot distinguish them (AUC<0.85), there may be a need for covariate depending upon the decrease in AUC. When the distinguishing power of PSA, a prostate cancer biomarker, is evaluated using ROC analysis, AUC adjusted based on age has a higher value compared to unadjusted AUC.
In the model employed, contribution of a single covariate to the diagnostic power of the biomarker was evaluated. It could be beneficial to investigate what the results might be using a different approach in which two or more covariates are employed.
